Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction
Authors
Keywords
-
Journal
BRAIN BEHAVIOR AND IMMUNITY
Volume 108, Issue -, Pages 302-308
Publisher
Elsevier BV
Online
2022-12-19
DOI
10.1016/j.bbi.2022.12.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olfactory loss and brain connectivity after COVID ‐19
- (2022) Fabrizio Esposito et al. HUMAN BRAIN MAPPING
- Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study
- (2022) Arianna Di Stadio et al. Brain Sciences
- Prokineticin-Receptor Network: Mechanisms of Regulation
- (2022) Roberta Lattanzi et al. Life-Basel
- Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
- (2022) Daniela Maftei et al. Current Neuropharmacology
- Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2—results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)
- (2022) Constantin A. Hintschich et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Investigational drugs for the treatment of olfactory dysfunction
- (2022) Arianna Di Stadio et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health
- (2022) Richard L. Doty TRENDS IN MOLECULAR MEDICINE
- Increase of Prokineticin‐2 in Serum of Patients with Parkinson's Disease
- (2021) Tommaso Schirinzi et al. MOVEMENT DISORDERS
- The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
- (2021) Roberta Lattanzi et al. Frontiers in Pharmacology
- Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder
- (2021) Ambra Stefani et al. BRAIN
- Smell impairment in patients with chronic rhinosinusitis: a real-life study
- (2021) Giulio Cesare Passali et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
- (2021) Annalisa Noce et al. Pharmaceuticals
- Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
- (2021) Zhongyuan Bao et al. Nature Communications
- Effectiveness of aprepitant in post‐acute COVID19 syndrome
- (2021) Rocío Reinoso‐Arija et al. Clinical Case Reports
- Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment
- (2021) Riffat Mehboob BIOMEDICINE & PHARMACOTHERAPY
- What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
- (2021) Paola Tirassa et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neurodegeneration-Associated Proteins in Human Olfactory Neurons Collected by Nasal Brushing
- (2020) Lorenzo Brozzetti et al. Frontiers in Neuroscience
- COVID-19: dealing with a potential risk factor for chronic neurological disorders
- (2020) Tommaso Schirinzi et al. JOURNAL OF NEUROLOGY
- Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
- (2020) Rafal Butowt et al. NEUROSCIENTIST
- The PROK2/PROKR2 Signaling Pathway is Required for the Migration of Most Olfactory Bulb Interneurons
- (2019) Yan Wen et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
- (2019) Roberta Lattanzi et al. Cells
- PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor
- (2018) Roberta Lattanzi et al. NEUROPEPTIDES
- The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
- (2018) Lucia Negri et al. PHYSIOLOGICAL REVIEWS
- Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes
- (2018) Matthew Neal et al. GLIA
- Nasal symptoms, epithelial injury and neurogenic inflammation in elite swimmers
- (2018) Brecht Steelant et al. RHINOLOGY
- The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders
- (2017) M. Brittany Johnson et al. Frontiers in Cellular Neuroscience
- Neuropeptide substance P and the immune response
- (2016) Alireza Mashaghi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
- (2016) Richard Gordon et al. Nature Communications
- How to assess olfactory performance with the Sniffin’ Sticks test ®
- (2016) C. Rumeau et al. European Annals of Otorhinolaryngology-Head and Neck Diseases
- Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase
- (2014) Q. Wang et al. JOURNAL OF NEUROSCIENCE
- A Test for Creutzfeldt–Jakob Disease Using Nasal Brushings
- (2014) Christina D. Orrú et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases
- (2013) Francesca Tavano et al. DIGESTIVE AND LIVER DISEASE
- Mitochondrial Ca2+ mobilization is a key element in olfactory signaling
- (2012) Daniela Fluegge et al. NATURE NEUROSCIENCE
- Peripheral modulation of smell: Fact or fiction?
- (2012) Mary T. Lucero SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started